Author:
Patel Saraswati,Jain Sonika,Gururani Ritika,Sharma Swapnil,Dwivedi Jaya
Publisher
Springer Science and Business Media LLC
Reference96 articles.
1. Greunen DG, Cordier W, Nell M, Westhuyzen CV, Steenkamp V, Panayides JL, et al. Targeting Alzheimer’s disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil. Eur J Med Chem. 2019;127:671–90.
2. Akhoon BA, Choudhary S, Tiwari H, Kumar A, Barik MR, Rathor L, et al. Discovery of a new donepezil-like acetylcholinesterase inhibitor for targeting Alzheimer’s disease: computational studies with biological validation. J Chem Inf Model. 2020;60:4717–29.
3. Doody RS, Cummings JL, Farlow MR. Reviewing the role of donepezil in the treatment of Alzheimer’s disease. Curr Alzheimer Res. 2012;9:773–81.
4. Cacabelos R. Donepezil in Alzheimer’s disease: from conventional trials to pharmacogenetics. Neuropsychiatr Dis Treat. 2007;3:303–33.
5. Jain S, Bisht A, Verma K, Negi S, Paliwal S, Sharma S. The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer’s disease. Cell Biochem Funct. 2021;40:1–12.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献